SCHEMBL21048950

SCHEMBL21048950

COc1ccc(CN2C(=O)CCc3c(OCC4(C(=O)O)CCN(c5cc(F)c(Br)cc5F)CC4)ccc(F)c32)cc1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 3/20 0.33
▸ PTGDR2 Q9Y5Y4 2/20 0.33
▸ FFAR4 Q5NUL3 1/20 0.33
▸ MDH2 P40926 1/20 0.32
▸ CACNA1G O43497 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ TP53 P04637 2/20 0.32
▸ CXCR3 P49682 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ GRM2 Q14416 2/20 0.32
▸ PTGER4 P35408 1/20 0.32
▸ PTGER2 P43116 1/20 0.32
▸ PTGDR Q13258 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ PARK7 Q99497 1/20 0.32
▸ PARP1 P09874 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17542975 0.94 PTGDR2 (0.34) KCNH2PTGDR2FFAR4CACNA1GKDM4E
SCHEMBL17543278 0.92 KMT2A (0.38) HTTMEN1POLBKMT2A
SCHEMBL17542910 0.92 PTGDR2 (0.34) KCNH2PTGDR2FFAR4CACNA1GKDM4E
SCHEMBL17544008 0.91 DDB1 (0.38) PTGDR2TP53THRBPTGER2PARP1
SCHEMBL17542917 0.90 CHRM4 (0.38) KCNH2PTGDR2CACNA1GKDM4EHTT
SCHEMBL17543674 0.90 PTGDR2 (0.39) KCNH2PTGDR2FFAR4HTTTP53
SCHEMBL17543094 0.89 TP53 (0.35) KCNH2PTGDR2CACNA1GKDM4EHTT
SCHEMBL17542704 0.89 PTGDR2 (0.34) KCNH2PTGDR2FFAR4CACNA1GKDM4E
SCHEMBL17543294 0.89 KDM4E (0.34) KCNH2PTGDR2FFAR4CACNA1GKDM4E
SCHEMBL17543858 0.89 GRM2 (0.36) KCNH2PTGDR2FFAR4CXCR3GRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3186240-B1 HETEROBICYCLIC COMPOUNDS AND THEIR USE FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMA CO LTD (JP) 2019-06-12 — — EP disclosed
Send feedback